JENNY MINTON: Open Payments
NPI 1619590098 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 11 payments from 8 companies in 2025. Trend: 2023 $2,293 · 2024 $1,863 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $54 |
| Astellas Pharma US Inc | 2 | $44 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
Products named: Xtandi, Rybelsus, JEMPERLI, Cologuard Collection Kit, FARXIGA, NINLARO, IMBRUVICA, Ozempic.
Industry payments across AL — which companies pay providers there.
